Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Plos One|November 6, 2020
Expression, purification and characterization of α-synuclein fibrillar specific scFv from inclusion bodiesVijay Gupta, Indulekha P Sudhakaran, Zeyaul Islam, et al.
Journal of Physiology and Biochemistry|February 1, 2026
The emerging role of calsequestrin 2: from calcium sensor and modulator to arrhythmia driverHumam Emad Rajha, Baha H Abuajameia, Ali Mohamed Barhoma, et al.
Biosensors & Bioelectronics|June 10, 2026
Differential kinetics of SARS-CoV-2 proteases revealed by a two-color, BRET-based dual protease biosensor, DuProSenseAsma Fatima, Anupriya M Geethakumari, S M Nasir Uddin, et al.
The Journal of Biological Chemistry|May 21, 2017
The origin and evolution of human glutaminases and their atypical C-terminal ankyrin repeatsCamila Cristina Pasquali, Zeyaul Islam, Douglas Adamoski, et al.
Biochimie|August 10, 2018
N-terminal phosphorylation of glutaminase C decreases its enzymatic activity and cancer cell migrationCarolline Fernanda Rodrigues Ascenção, Raghavendra Sashi Krishna Nagampalli, Zeyaul Islam, et al.
Cell Death & Disease|October 20, 2023
Control of TGFβ signalling by ubiquitination independent function of E3 ubiquitin ligase TRIP12Kripa S Keyan, Safa Salim, Swetha Gowda, et al.
The FEBS Journal|January 28, 2022
Novel engineered nanobodies specific for N-terminal region of alpha-synuclein recognize Lewy-body pathology and inhibit in-vitro seeded aggregation and toxicityIssam Hmila, Nishant N Vaikath, Nour K Majbour, et al.
Nature Structural & Molecular Biology|October 19, 2023
Molecular mechanism of glutaminase activation through filamentation and the role of filaments in mitophagy protectionDouglas Adamoski, Marilia Meira Dias, Jose Edwin Neciosup Quesñay, et al.
Scientific Reports|February 24, 2018
Human mitochondrial pyruvate carrier 2 as an autonomous membrane transporterRaghavendra Sashi Krishna Nagampalli, José Edwin Neciosup Quesñay, Douglas Adamoski, et al.
Molecular Autism|October 26, 2019
Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autismHyung-Goo Kim, Jill A Rosenfeld, Daryl A Scott, et al.
Pageof 5